{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T16:33:37Z","timestamp":1722184417198},"reference-count":22,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,3,13]],"date-time":"2009-03-13T00:00:00Z","timestamp":1236902400000},"content-version":"vor","delay-in-days":11182,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Pharmacologica et Toxicologica"],"published-print":{"date-parts":[[1978,8]]},"abstract":"<jats:p><jats:bold>Abstract<\/jats:bold> The effects of melperone and thiothixene on the concentrations of monoamine metabolites in brain and prolactin in the serum of rats and mice were determined. Both drugs increased brain concentrations of dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in a dosedependent manner. 5\u2010Hydroxyindoleacetic acid (5\u2010HIAA) was unaffected. The effect of thiothixene was longer lasting and about 5 times greater than that of melperone. Melperone, but not thiothixene, increased levels of 3\u2010methoxy\u20104\u2010hydroxyphenylethylene glycol (MOPEG). Several hours after administration of melperone, levels of HVA and MOPEG were diminished.<\/jats:p><jats:p>Both drugs increased prolactin concentrations in rat serum. Thiothixene was about 10 times more potent than melperone.<\/jats:p><jats:p>Of two urinary metabolites of melperone investigated, one caused the same qualitative effects on monoamine metabolism as melperone itself but with reduced potency. The other metabolite was ineffective.<\/jats:p>","DOI":"10.1111\/j.1600-0773.1978.tb02246.x","type":"journal-article","created":{"date-parts":[[2010,7,29]],"date-time":"2010-07-29T22:28:36Z","timestamp":1280442516000},"page":"129-136","source":"Crossref","is-referenced-by-count":17,"title":["Effect of Melperone, Two of its Metabolites and Thiothixene on Central Monoamine Metabolism and Prolactin Levels in Rodents"],"prefix":"10.1111","volume":"43","author":[{"given":"Frits\u2010Axel","family":"Wiesel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Bjerkenstedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Skett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,3,13]]},"reference":[{"issue":"4","key":"e_1_2_1_2_1","article-title":"Effects of melperone and thiothixene on prolactin levels in cerebrospinal fluid and plasma of psychotic women","volume":"224","author":"Bjerkenstedt L.","year":"1977","journal-title":"Archiv. Psychiat. Neurol. Sci."},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00341611"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00341708"},{"key":"e_1_2_1_5_1","first-page":"509","article-title":"Thiothixene versus trifluoperazine in newlyadmitted schizophrenic patients","volume":"8","author":"Bishop M.P.","year":"1966","journal-title":"Current Therap. Res."},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj1330529"},{"key":"e_1_2_1_7_1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1600-0773.1963.tb01730.x","article-title":"Effect of chlorpromazine or haloperidol on formation of 3\u2010methoxytyramine and normetanephrine in mouse brain","volume":"20","author":"Carlsson A.","year":"1963","journal-title":"Acta pharmacol. et toxicol."},{"key":"e_1_2_1_8_1","first-page":"713","article-title":"Activit\u00e9\u00e9lectrique unitaire des neurons de l'hypothalamus m\u00e9dio\u2010ventral et injections intraventriculaires de cat\u00e9cholamines. Sa confrontation avec les donn\u00e9es de l'histofluorescence et des dosages radio\u2010immunologiques","volume":"34","author":"Dufy B.","year":"1973","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"e_1_2_1_9_1","first-page":"421","volume-title":"Antipsychotic Drugs: Pharmacodynamics and Pharmacokinetics","author":"Frantz A.","year":"1976"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(74)90143-X"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-475560-4.50008-5"},{"key":"e_1_2_1_12_1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000468080","article-title":"Klinische Erfahrungen mit Methylperon (BuronilR), einem neuen Butyrophenonderivat","volume":"5","author":"Gross H.","year":"1970","journal-title":"Int. Pharmacopsychiat."},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1976.tb00103.x"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(73)90054-X"},{"key":"e_1_2_1_15_1","unstructured":"Larsson H.:Metabolism of \u03b3\u2010(4\u2010methylpiperidino)\u2010p\u2010fluorobutyrophenone hydrochloride (FG 5111) in laboratory animals.Internal report from the department of biochemistry AB Ferrosan Malm\u00f6 Sweden 1968."},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1966.tb07881.x"},{"key":"e_1_2_1_17_1","first-page":"605","article-title":"Kliniske fors\u00f8g med et nyt butyrofenonderivat, BuronilR (Fg 5111) ved svaer kronisk skizofreni","volume":"73","author":"Schulsinger F.","year":"1965","journal-title":"Nord. Med."},{"key":"e_1_2_1_18_1","first-page":"127","volume-title":"Handbook of Psychopharmacology","author":"Sedvall G.","year":"1975"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00423253"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02205228"},{"key":"e_1_2_1_21_1","first-page":"171","volume-title":"Advences in Mass Spectrometry in Biochemistry and Medicine","author":"Wiesel F.\u2010A.","year":"1976"},{"key":"e_1_2_1_22_1","first-page":"199","volume-title":"Antipsychotic Drugs: Pharmacodynamics and Pharmacokinetics","author":"Wiesel F.\u2010A.","year":"1976"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1977.tb06671.x"}],"container-title":["Acta Pharmacologica et Toxicologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0773.1978.tb02246.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0773.1978.tb02246.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T16:25:01Z","timestamp":1699374301000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0773.1978.tb02246.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1978,8]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1978,8]]}},"alternative-id":["10.1111\/j.1600-0773.1978.tb02246.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0773.1978.tb02246.x","archive":["Portico"],"relation":{},"ISSN":["0001-6683"],"issn-type":[{"value":"0001-6683","type":"print"}],"subject":[],"published":{"date-parts":[[1978,8]]}}}